Randomized, Double-Blind, Phase II, Multicenter Study Evaluating the Safety/Tolerability and Efficacy of JNJ-Q2, a Novel Fluoroquinolone, Compared with Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infection

JNJ-Q2 is a fluoroquinolone with broad coverage including methicillin-resistant Staphylococcus aureus (MRSA). A double-blind, multicenter, phase II noninferiority study treated 161 patients for 7 to 14 days, testing the efficacy of JNJ-Q2 (250 mg, twice a day [BID]) versus linezolid (600 mg, BID) in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Covington, Paul, Davenport, J. Michael, Andrae, David, O'Riordan, William, Liverman, Lisa, McIntyre, Gail, Almenoff, June
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232810/
https://ncbi.nlm.nih.gov/pubmed/21947389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05044-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados